"this means that for the first time, an injectionfree regimen will be recommended for all patients with rifampicin resistant tuberculosis in south africa.

motsoaledi bekakhuluma emhlanganweni webetindza ba losandza kubanjwa lapho beketfula khona umtsetfo sivivinyo wekuchitjelwa kwetindzaba tenhi kanye nemtsetfosivivinyo wekuchi bela tindzaba tetikimu tete kwelashwa.
